Sustained response of refractory chronic lymphocytic leukemia in progression complicated by acute hemolitic anemia to anti-CD20 monoclonal antibody

Blood. 2002 Feb 1;99(3):1096-7. doi: 10.1182/blood.v99.3.1096a.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Acute Disease
  • Anemia, Hemolytic / drug therapy*
  • Anemia, Hemolytic / etiology
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / administration & dosage
  • Follow-Up Studies
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / complications
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Lymphocytosis / drug therapy
  • Male
  • Middle Aged
  • Remission Induction
  • Rituximab
  • Salvage Therapy

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab